In the current studies, we dissected the mechanisms that explain how PD-1 signaling interacts with STAT3 deficiency in donor T cells to prevent GVHD while maintaining GVL activity in a murine model of MHC-mismatched HCT. Here, PDCD1 is linked to graft versus host disease.